{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bimatoprost", "glaucoma", "in situ gel", "niosomes", "ocular delivery"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37960016", "DateRevised": {"Year": "2023", "Month": "11", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "06"}], "Language": ["eng"], "ELocationID": ["4336", "10.3390/polym15214336"], "Journal": {"ISSN": "2073-4360", "JournalIssue": {"Volume": "15", "Issue": "21", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "06"}}, "Title": "Polymers", "ISOAbbreviation": "Polymers (Basel)"}, "ArticleTitle": "Ophthalmic Bimatoprost-Loaded Niosomal In Situ Gel: Preparation, Optimization, and In Vivo Pharmacodynamics Study.", "Abstract": {"AbstractText": ["This study aimed at formulating the antiglaucoma agent, Bimatoprost (BMT), into niosomal in situ gel (BMT-ISG) for ocular delivery. Niosomes containing cholesterol/span 60 entrapping BMT were fabricated using a thin-film hydration method. The fabricated niosomes were optimized and characterized for entrapment efficiency (%EE) and size. The optimized BMT-loaded niosomal formulation prepared at a cholesterol/span 60 ratio of 1:2 exhibited the highest entrapment (81.2 \u00b1 1.2%) and a small particle size (167.3 \u00b1 9.1 nm), and they were selected for incorporation into in situ gelling systems (BMT-ISGs) based on Pluronic F127/Pluronic F68. Finally, the in vivo efficiency of the BMT-ISG formulation, in terms of lowering the intraocular pressure (IOP) in normotensive male albino rabbits following ocular administration, was assessed and compared to that of BMT ophthalmic solution. All the formulated BMT-ISGs showed sol-gel transition temperatures ranging from 28.1 \u00b0C to 40.5 \u00b1 1.6 \u00b0C. In addition, the BMT-ISG formulation sustained in vitro BMT release for up to 24 h. Interestingly, in vivo experiments depicted that topical ocular administration of optimized BMT-ISG formulation elicited a significant decline in IOP, with maximum mean decreases in IOP of 9.7 \u00b1 0.6 mm Hg, compared to BMT aqueous solution (5.8 \u00b1 0.6 mm Hg). Most importantly, no signs of irritation to the rabbit's eye were observed following topical ocular administration of the optimized BMT-ISG formulation. Collectively, our results suggested that niosomal in situ gels might be a feasible delivery vehicle for topical ocular administration of anti-glaucoma agents, particularly those with poor ocular bioavailability."]}, "AuthorList": [{"Identifier": ["0000-0003-1298-4863"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Aldawsari", "ForeName": "Mohammed F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, Medicinal and Aromatic Plants Research Institute, National Center for Research, Khartoum 2404, Sudan."}], "LastName": "Moglad", "ForeName": "Ehssan H", "Initials": "EH"}, {"Identifier": ["0000-0003-2821-9373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint AbdulRahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Hadil Faris", "Initials": "HF"}, {"Identifier": ["0000-0002-6983-8587"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Alkahtani", "ForeName": "Hamad M", "Initials": "HM"}, {"Identifier": ["0000-0002-3741-0893"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Khafagy", "ForeName": "El-Sayed", "Initials": "ES"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Polymers (Basel)", "NlmUniqueID": "101545357", "ISSNLinking": "2073-4360"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agrahari V., Mandal A., Trinh H.M., Joseph M., Ray A., Hadji H., Mitra R., Pal D., Mitra A.K. A comprehensive insight on ocular pharmacokinetics. Drug Deliv. Transl. Res. 2016;6:735\u2013754. doi: 10.1007/s13346-016-0339-2.", "ArticleIdList": ["10.1007/s13346-016-0339-2", "PMC5319401", "27798766"]}, {"Citation": "Akhter M.H., Ahmad I., Alshahrani M.Y., Al-Harbi A.I., Khalilullah H., Afzal O., Altamimi A.S.A., Najib Ullah S.N., Ojha A., Karim S. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels. 2022;8:82. doi: 10.3390/gels8020082.", "ArticleIdList": ["10.3390/gels8020082", "PMC8871777", "35200463"]}, {"Citation": "Varela-Fern\u00e1ndez R., D\u00edaz-Tom\u00e9 V., Luaces-Rodr\u00edguez A., Conde-Penedo A., Garc\u00eda-Otero X., Luzardo-\u00c1lvarez A., Fern\u00e1ndez-Ferreiro A., Otero-Espinar F.J. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics. 2020;12:269. doi: 10.3390/pharmaceutics12030269.", "ArticleIdList": ["10.3390/pharmaceutics12030269", "PMC7151081", "32188045"]}, {"Citation": "Patel A., Cholkar K., Agrahari V., Mitra A.K. Ocular drug delivery systems: An overview. World J. Pharmacol. 2013;2:47\u201364. doi: 10.5497/wjp.v2.i2.47.", "ArticleIdList": ["10.5497/wjp.v2.i2.47", "PMC4289909", "25590022"]}, {"Citation": "Tsung T.-H., Chen Y.-H., Lu D.-W. Updates on Biodegradable Formulations for Ocular Drug Delivery. Pharmaceutics. 2023;15:734. doi: 10.3390/pharmaceutics15030734.", "ArticleIdList": ["10.3390/pharmaceutics15030734", "PMC10057390", "36986595"]}, {"Citation": "Yuan X., Marcano D.C., Shin C.S., Hua X., Isenhart L.C., Pflugfelder S.C., Acharya G. Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy. ACS Nano. 2015;9:1749\u20131758. doi: 10.1021/nn506599f.", "ArticleIdList": ["10.1021/nn506599f", "25585134"]}, {"Citation": "Verma A., Tiwari A., Saraf S., Panda P.K., Jain A., Jain S.K. Emerging potential of niosomes in ocular delivery. Expert Opin. Drug Deliv. 2021;18:55\u201371. doi: 10.1080/17425247.2020.1822322.", "ArticleIdList": ["10.1080/17425247.2020.1822322", "32903034"]}, {"Citation": "Durak S., Esmaeili Rad M., Alp Yetisgin A., Eda Sutova H., Kutlu O., Cetinel S., Zarrabi A. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects. Nanomaterials. 2020;10:1191. doi: 10.3390/nano10061191.", "ArticleIdList": ["10.3390/nano10061191", "PMC7353242", "32570885"]}, {"Citation": "Hamsika M., Gowda D.V., Vindru J., Moin A. Nanotechnology for Ophthalmic Preparations. Int. J. Curr. Pharm. Res. 2016;8:5\u201311."}, {"Citation": "Kaur I.P., Garg A., Singla A.K., Aggarwal D. Vesicular systems in ocular drug delivery: An overview. Int. J. Pharm. 2004;269:1\u201314. doi: 10.1016/j.ijpharm.2003.09.016.", "ArticleIdList": ["10.1016/j.ijpharm.2003.09.016", "14698571"]}, {"Citation": "Gupta P., Yadav K.S. Formulation and evaluation of brinzolamide encapsulated niosomal in-situ gel for sustained reduction of IOP in rabbits. J. Drug Deliv. Sci. Technol. 2022;67:103004. doi: 10.1016/j.jddst.2021.103004.", "ArticleIdList": ["10.1016/j.jddst.2021.103004"]}, {"Citation": "Kouchak M. In situ gelling systems for drug delivery. Jundishapur J. Nat. Pharm. Prod. 2014;9:e20126. doi: 10.17795/jjnpp-20126.", "ArticleIdList": ["10.17795/jjnpp-20126", "PMC4165193", "25237648"]}, {"Citation": "Wu Y., Liu Y., Li X., Kebebe D., Zhang B., Ren J., Lu J., Li J., Du S., Liu Z. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J. Pharm. Sci. 2019;14:1\u201315. doi: 10.1016/j.ajps.2018.04.008.", "ArticleIdList": ["10.1016/j.ajps.2018.04.008", "PMC7032175", "32104434"]}, {"Citation": "Obiedallah M.M., Abdel-Mageed A.M., Elfaham T.H. Ocular administration of acetazolamide microsponges in situ gel formulations. Saudi Pharm. J. 2018;26:909\u2013920. doi: 10.1016/j.jsps.2018.01.005.", "ArticleIdList": ["10.1016/j.jsps.2018.01.005", "PMC6218851", "30416345"]}, {"Citation": "Irimia T., Dinu-P\u00eervu C.E., Ghica M.V., Lupuleasa D., Muntean D.L., Udeanu D.I., Popa L. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review. Mar. Drugs. 2018;16:373. doi: 10.3390/md16100373.", "ArticleIdList": ["10.3390/md16100373", "PMC6212818", "30304825"]}, {"Citation": "Kumar D., Jain N., Gulati N., Nagaich U. Nanoparticles laden in situ gelling system for ocular drug targeting. J. Adv. Pharm. Technol. Res. 2013;4:9\u201317. doi: 10.4103/2231-4040.107495.", "ArticleIdList": ["10.4103/2231-4040.107495", "PMC3645361", "23662277"]}, {"Citation": "Abbas M.N., Khan S.A., Sadozai S.K., Khalil I.A., Anter A., Fouly M.E., Osman A.H., Kazi M. Nanoparticles Loaded Thermoresponsive in Situ Gel for Ocular Antibiotic Delivery against Bacterial Keratitis. Polymers. 2022;14:1135. doi: 10.3390/polym14061135.", "ArticleIdList": ["10.3390/polym14061135", "PMC8951139", "35335465"]}, {"Citation": "Batrakova E.V., Kabanov A.V. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control Release. 2008;130:98\u2013106. doi: 10.1016/j.jconrel.2008.04.013.", "ArticleIdList": ["10.1016/j.jconrel.2008.04.013", "PMC2678942", "18534704"]}, {"Citation": "Kadam Y., Yerramilli U., Bahadur A. Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: Effect of molecular characteristics, temperature and added salt on the solubilizing capacity. Colloids Surf. B Biointerfaces. 2009;72:141\u2013147. doi: 10.1016/j.colsurfb.2009.03.027.", "ArticleIdList": ["10.1016/j.colsurfb.2009.03.027", "19403275"]}, {"Citation": "Singla P., Singh O., Sharma S., Betlem K., Aswal V.K., Peeters M., Mahajan R.K. Temperature-Dependent Solubilization of the Hydrophobic Antiepileptic Drug Lamotrigine in Different Pluronic Micelles\u2014A Spectroscopic, Heat Transfer Method, Small-Angle Neutron Scattering, Dynamic Light Scattering, and in Vitro Release Study. ACS Omega. 2019;4:11251\u201311262. doi: 10.1021/acsomega.9b00939.", "ArticleIdList": ["10.1021/acsomega.9b00939", "PMC6648490", "31460227"]}, {"Citation": "Ibrahim el S.A., Ismail S., Fetih G., Shaaban O., Hassanein K., Abdellah N.H. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application. Acta Pharm. 2012;62:59\u201370. doi: 10.2478/v10007-012-0009-y.", "ArticleIdList": ["10.2478/v10007-012-0009-y", "22472449"]}, {"Citation": "Akash M.S.H., Rehman K. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. J. Control. Release. 2015;209:120\u2013138. doi: 10.1016/j.jconrel.2015.04.032.", "ArticleIdList": ["10.1016/j.jconrel.2015.04.032", "25921088"]}, {"Citation": "El-Kamel A.H. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm. 2002;241:47\u201355. doi: 10.1016/S0378-5173(02)00234-X.", "ArticleIdList": ["10.1016/S0378-5173(02)00234-X", "12086720"]}, {"Citation": "Varshosaz J., Tabbakhian M., Salmani Z. Designing of a Thermosensitive Chitosan/Poloxamer In Situ Gel for OcularDelivery of Ciprofloxacin. Open Drug Deliv. J. 2008;2:61\u201370. doi: 10.2174/1874126600802010061.", "ArticleIdList": ["10.2174/1874126600802010061"]}, {"Citation": "Lin H.R., Sung K.C., Vong W.J. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine. Biomacromolecules. 2004;5:2358\u20132365. doi: 10.1021/bm0496965.", "ArticleIdList": ["10.1021/bm0496965", "15530052"]}, {"Citation": "Aldawsari M.F., Khafagy E.S., Moglad E.H., Selim Abu Lila A. Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine. Saudi Pharm. J. 2023;31:101734. doi: 10.1016/j.jsps.2023.101734.", "ArticleIdList": ["10.1016/j.jsps.2023.101734", "PMC10462889", "37649675"]}, {"Citation": "Hagbani T.A., Yadav H., Moin A., Lila A.S.A., Mehmood K., Alshammari F., Khan S., Khafagy E.S., Hussain T., Rizvi S.M.D., et al. Enhancement of Vancomycin Potential against Pathogenic Bacterial Strains via Gold Nano-Formulations: A Nano-Antibiotic Approach. Materials. 2022;15:1108. doi: 10.3390/ma15031108.", "ArticleIdList": ["10.3390/ma15031108", "PMC8840600", "35161053"]}, {"Citation": "Satyanarayana S.D., Abu Lila A.S., Moin A., Moglad E.H., Khafagy E.S., Alotaibi H.F., Obaidullah A.J., Charyulu R.N. Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma. Pharmaceuticals. 2023;16:1001. doi: 10.3390/ph16071001.", "ArticleIdList": ["10.3390/ph16071001", "PMC10385266", "37513913"]}, {"Citation": "Khafagy E.S., Almutairy B.K., Abu Lila A.S. Tailoring of Novel Bile Salt Stabilized Vesicles for Enhanced Transdermal Delivery of Simvastatin: A New Therapeutic Approach against Inflammation. Polymers. 2023;15:677. doi: 10.3390/polym15030677.", "ArticleIdList": ["10.3390/polym15030677", "PMC9921379", "36771977"]}, {"Citation": "Al Saqr A., Wani S.U., Gangadharappa H.V., Aldawsari M.F., Khafagy E.-S., Lila A.S.A. Enhanced Cytotoxic Activity of Docetaxel-Loaded Silk Fibroin Nanoparticles against Breast Cancer Cells. Polymers. 2021;13:1416. doi: 10.3390/polym13091416.", "ArticleIdList": ["10.3390/polym13091416", "PMC8123888", "33925581"]}, {"Citation": "Balasubramaniam J., Pandit J.K. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv. 2003;10:185\u2013191. doi: 10.1080/713840402.", "ArticleIdList": ["10.1080/713840402", "12944139"]}, {"Citation": "Allam A., Elsabahy M., El Badry M., Eleraky N.E. Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma. Int. J. Pharm. 2021;598:120380. doi: 10.1016/j.ijpharm.2021.120380.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120380", "33609725"]}, {"Citation": "Teba H.E., Khalil I.A., El Sorogy H.M. Novel cubosome based system for ocular delivery of acetazolamide. Drug Deliv. 2021;28:2177\u20132186. doi: 10.1080/10717544.2021.1989090.", "ArticleIdList": ["10.1080/10717544.2021.1989090", "PMC8528410", "34662264"]}, {"Citation": "Moghassemi S., Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J. Control Release. 2014;185:22\u201336. doi: 10.1016/j.jconrel.2014.04.015.", "ArticleIdList": ["10.1016/j.jconrel.2014.04.015", "24747765"]}, {"Citation": "Dabbagh Moghaddam F., Akbarzadeh I., Marzbankia E., Farid M., Khaledi L., Reihani A.H., Javidfar M., Mortazavi P. Delivery of melittin-loaded niosomes for breast cancer treatment: An in vitro and in vivo evaluation of anti-cancer effect. Cancer Nanotechnol. 2021;12:14. doi: 10.1186/s12645-021-00085-9.", "ArticleIdList": ["10.1186/s12645-021-00085-9"]}, {"Citation": "Mohanty D., Rani M.J., Haque M.A., Bakshi V., Jahangir M.A., Imam S.S., Gilani S.J. Preparation and evaluation of transdermal naproxen niosomes: Formulation optimization to preclinical anti-inflammatory assessment on murine model. J. Liposome Res. 2020;30:377\u2013387. doi: 10.1080/08982104.2019.1652646.", "ArticleIdList": ["10.1080/08982104.2019.1652646", "31412744"]}, {"Citation": "Qumbar M., Ameeduzzafar, Imam S.S., Ali J., Ahmad J., Ali A. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity. Biomed. Pharmacother. 2017;93:255\u2013266. doi: 10.1016/j.biopha.2017.06.043.", "ArticleIdList": ["10.1016/j.biopha.2017.06.043", "28738502"]}, {"Citation": "Mokhtar M., Sammour O.A., Hammad M.A., Megrab N.A. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int. J. Pharm. 2008;361:104\u2013111. doi: 10.1016/j.ijpharm.2008.05.031.", "ArticleIdList": ["10.1016/j.ijpharm.2008.05.031", "18577437"]}, {"Citation": "Balakrishnan P., Shanmugam S., Lee W.S., Lee W.M., Kim J.O., Oh D.H., Kim D.-D., Kim J.S., Yoo B.K., Choi H.-G., et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int. J. Pharm. 2009;377:1\u20138. doi: 10.1016/j.ijpharm.2009.04.020.", "ArticleIdList": ["10.1016/j.ijpharm.2009.04.020", "19394413"]}, {"Citation": "Ghazwani M., Hani U., Alam A., Alqarni M.H. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route. Gels. 2023;9:401. doi: 10.3390/gels9050401.", "ArticleIdList": ["10.3390/gels9050401", "PMC10217970", "37232993"]}, {"Citation": "Jiang S., Franco Y.L., Zhou Y., Chen J. Nanotechnology in retinal drug delivery. Int. J. Ophthalmol. 2018;11:1038\u20131044. doi: 10.18240/ijo.2018.06.23.", "ArticleIdList": ["10.18240/ijo.2018.06.23", "PMC6010371", "29977820"]}, {"Citation": "Alshammari F., Alshammari B., Moin A., Alamri A., Al Hagbani T., Alobaida A., Baker A., Khan S., Rizvi S.M.D. Ceftriaxone Mediated Synthesized Gold Nanoparticles: A Nano-Therapeutic Tool to Target Bacterial Resistance. Pharmaceutics. 2021;13:1896. doi: 10.3390/pharmaceutics13111896.", "ArticleIdList": ["10.3390/pharmaceutics13111896", "PMC8622407", "34834310"]}, {"Citation": "Gupta H., Jain S., Mathur R., Mishra P., Mishra A.K., Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv. 2007;14:507\u2013515. doi: 10.1080/10717540701606426.", "ArticleIdList": ["10.1080/10717540701606426", "18027180"]}, {"Citation": "Trucillo P. Drug Carriers: A Review on the Most Used Mathematical Models for Drug Release. Processes. 2022;10:1094. doi: 10.3390/pr10061094.", "ArticleIdList": ["10.3390/pr10061094"]}, {"Citation": "Kaur I.P., Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 2002;28:353\u2013369. doi: 10.1081/DDC-120002997.", "ArticleIdList": ["10.1081/DDC-120002997", "12056529"]}, {"Citation": "Wadetwar R.N., Agrawal A.R., Kanojiya P.S. In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: In-vitro and ex-vivo evaluation. J. Drug Deliv. Sci. Technol. 2020;56:101575. doi: 10.1016/j.jddst.2020.101575.", "ArticleIdList": ["10.1016/j.jddst.2020.101575"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "29"}, {"Year": "2023", "Month": "10", "Day": "29"}, {"Year": "2023", "Month": "11", "Day": "1"}, {"Year": "2023", "Month": "11", "Day": "14", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "11", "Day": "14", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "14", "Hour": "2", "Minute": "17"}, {"Year": "2023", "Month": "11", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["37960016", "PMC10649908", "10.3390/polym15214336", "polym15214336"]}}], "PubmedBookArticle": []}